Intellia Therapeutics, Inc. (NTLA)
11.65
-0.19
(-1.60%)
USD |
NASDAQ |
Oct 21, 16:00
11.60
-0.05
(-0.43%)
After-Hours: 20:00
Intellia Therapeutics Net Income (Annual) : -412.69M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -412.69M |
| December 31, 2024 | -519.02M |
| December 31, 2023 | -481.19M |
| December 31, 2022 | -474.19M |
| December 31, 2021 | -267.89M |
| December 31, 2020 | -134.23M |
| Date | Value |
|---|---|
| December 31, 2019 | -99.53M |
| December 31, 2018 | -85.34M |
| December 31, 2017 | -67.54M |
| December 31, 2016 | -31.63M |
| December 31, 2015 | -12.40M |
| December 31, 2014 | -9.539M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Twist Bioscience Corp. | -77.67M |
| Beam Therapeutics, Inc. | -79.99M |
| Prime Medicine, Inc. | -201.14M |
| 10X Genomics, Inc. | -43.54M |
| Moderna, Inc. | -2.822B |